Evidence map›Paper›PMID 41975646›Full record

ArticleZhongguo fei ai za zhi = Chinese journal of lung cancer2026

[Impact of HIF-1α-expressing Cellular Subpopulations on Lymph Node Metastasis 
and Postoperative Recurrence in Non-small Cell Lung Cancer].

Fanghan Cao, Qianhui Chen, Liying Yang, Miaoqing Zhao, Xiaorong Sun, Ligang Xing

Abstract readEnglish Abstract
In one paragraph

Article in Zhongguo fei ai za zhi = Chinese journal of lung cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Fanghan CaoDepartment of Graduate, Shandong First Medical University (Shandong Academy of Medical Sciences), Jinan 250117, China.
Qianhui ChenDepartment of Graduate, Shandong First Medical University (Shandong Academy of Medical Sciences), Jinan 250117, China.
Liying YangDepartment of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University (Shandong Academy of Medical Sciences) (Shandong Cancer Research Institute), Jinan 250117, China.
Miaoqing ZhaoDepartment of Pathology, Shandong Cancer Hospital and Institute, Shandong First Medical University (Shandong Academy of Medical Sciences) (Shandong Cancer Research Institute), Jinan 250117, China.
Xiaorong SunDepartment of Nuclear Medicine, Shandong Cancer Hospital and Institute, Shandong First Medical University (Shandong Academy of Medical Sciences) (Shandong Cancer Research Institute), Jinan 250117, China.
Ligang XingDepartment of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University (Shandong Academy of Medical Sciences) (Shandong Cancer Research Institute), Jinan 250117, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNon-small cell lung cancer (NSCLC) is associated with a high rate of postoperative recurrence, and conventional tumor-node-metastasis (TNM) staging does not fully reflect its biological heterogeneity. Hypoxia-inducible factor-1alpha (HIF-1α) plays a critical role in tumor progression and remodeling of the tumor immune microenvironment. However, the spatial distribution of HIF-1α and its prognostic significance in the context of different lymph node metastatic states remain unclear. This study aimed to investigate the densities of HIF-1α-expressing tumor cells, CD4+ T cells, and CD8+ T cells in the primary tumors of NSCLC patients, and to assess their associations with lymph node metastasis and postoperative recurrence.

methods256 formalin-fixed paraffin-embedded primary tumor specimens from NSCLC patients who underwent radical resection at Shandong First Medical University Affiliated Cancer Hospital between January 1, 2014 and December 31, 2018 were retrospectively collected. Tissue microarrays containing both tumor center (TC) and invasive margin (IM) regions were constructed and multiplex immunofluorescence staining [HIF-1α/CD4/CD8/cytokeratin (CK)/4',6-diamidino-2-phenylindole (DAPI)] were performed to quantitatively analyze the densities of HIF-1α-expressing tumor cells (HIF-1α+CK+), HIF-1α+CD4+ T cells and HIF-1α+CD8+ T cells. Mann-Whitney U tests were used to compare cellular density differences between N0 versus N1-2 groups and N1 versus N2 subgroups, while Cox proportional hazards regression models were employed to identify critical recurrence-associated factors.

resultsThe study ultimately included 256 patients with stage IA-IIIB NSCLC, with a median follow-up duration of 37.05 months, during which 87 cases (34.0%) experienced recurrence. Comparative analysis revealed that in both TC and IM regions, the N1-2 group exhibited significantly higher densities of HIF-1α+CK+ cells (P values: 0.039 and <0.001, respectively) and lower densities of HIF-1α+CD8+ cells (both P values: <0.001) compared to the N0 group, while no statistically significant differences were observed in the densities of HIF-1α+CK+ cells, HIF-1α+CD4+ cells, or HIF-1α+CD8+ cells between N1 and N2 subgroups within either TC or IM regions (all P>0.05). Multivariate Cox regression analysis showed that, among N0 patients, a low density of HIF-1α+CD8+ cells in the TC was an independent risk factor for recurrence in NSCLC patients [hazard ratio (HR)=1.998, 95%CI: 1.077-3.705, P=0.028]. In contrast, among N1 and N2 patients, the densities of HIF-1α+CK+ cells, HIF-1α+CD4+ T cells, and HIF-1α+CD8+ cells in both the TC and IM regions were not significantly associated with NSCLC recurrence.

conclusionsIn patients with NSCLC, lymph node metastasis is closely associated with alterations in the densities of HIF-1α-related cellular subpopulations in the primary tumor. A reduced density of HIF-1α+CD8+ cells in the TC of the primary lesion is significantly associated with postoperative recurrence in N0-stage NSCLC patients and may serve as a potential immunological marker for postoperative risk stratification.

Indexed as

Carcinoma, Non-Small-Cell LungHypoxia-Inducible Factor 1, alpha SubunitLung NeoplasmsNeoplasm Recurrence, LocalAdultAgedFemaleHumansLymphatic MetastasisMaleMiddle AgedPostoperative PeriodRetrospective StudiesHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitCD8+ T cellHypoxia-inducible factor-1alphaLung neoplasmsLymph node metastasisPrognosisRecurrence-free survival timeTumor center

Identifiers

PMID41975646
PMCPMC13078961

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.